Description

Odin Ostarine 30mg 30 Tablets (MK-2866 / Enobosarm)

Product Overview

Odin Ostarine (MK-2866), also known as Enobosarm or GTX-024, is a selective androgen receptor modulator (SARM) that has gained recognition in both clinical research and athletic performance circles. Originally developed by GTx, Inc. in collaboration with Merck & Co., Inc., Ostarine was designed to prevent and treat muscle wasting conditions such as cachexia and sarcopenia, as well as osteoporosis.

Each tablet contains 30mg of pharmaceutical-grade Ostarine, with 30 tablets per bottle, providing a complete cycle supply. This compound offers a unique approach to lean muscle preservation and joint health without the severe side effect profile associated with traditional anabolic steroids.

---

Mechanism of Action

Ostarine functions by selectively binding to androgen receptors in skeletal muscle and bone tissue. Unlike traditional anabolic steroids that affect androgen receptors throughout the body, Ostarine is engineered to minimize androgenic activity in tissues such as the prostate and skin. This tissue selectivity is the primary reason for its reduced side effect profile compared to conventional anabolic agents.

The compound exerts its effects through several key mechanisms:

• Enhanced protein synthesis, supporting muscle hypertrophy and maintenance

• Reduced protein breakdown by limiting atrophy-promoting pathways

• Promotion of satellite cell activity for muscle fiber repair

• Preservation of bone density through androgen receptor activation

---

Clinical Evidence

Ostarine has been the subject of multiple clinical trials demonstrating its efficacy and safety profile. A 12-week double-blind, placebo-controlled Phase II clinical trial showed that Ostarine increased lean muscle mass and improved physical function without the negative side effects typically seen with testosterone or other anabolic steroids.

In a Phase II clinical trial involving 159 cancer patients with cachexia, Ostarine met its primary endpoint of lean body mass increase. The 1mg and 3mg treatment cohorts demonstrated statistically significant increases in lean body mass of 1.5 kg and 1.3 kg respectively over 16 weeks, compared to 0.1 kg in the placebo group. The study also met secondary endpoints, including improved physical function as measured by stair climb performance.

Multiple placebo-controlled human studies demonstrate that Enobosarm at clinically tested doses produces statistically significant improvements in lean muscle mass.

---

Medical Applications

Ostarine was originally developed for the treatment of muscle wasting conditions and osteoporosis. Its therapeutic potential extends to:

• Cancer cachexia: Severe muscle wasting that affects approximately half of all cancer patients and is responsible for at least 20 percent of cancer deaths

• Sarcopenia: Age-related loss of skeletal muscle mass and function

• Osteoporosis: Bone density preservation through androgen receptor activation

• Nitrogen retention: Supporting overall protein balance in the body

Currently, there are no FDA-approved therapies available for cancer-induced muscle loss, making Ostarine a compound of significant clinical interest.

---

Athletic Performance Applications

Athletes and bodybuilders utilize Ostarine for its ability to promote lean muscle gains, increase strength, and support recovery while minimizing the side effects associated with traditional anabolic steroids.

Key athletic benefits include:

• Lean muscle mass accumulation without water retention

• Strength gains with minimal androgenic side effects

• Joint and tendon strengthening properties

• Minimal suppression of the hypothalamic-pituitary-testicular axis (HPTA) compared to anabolic steroids

Versatility in cycling:

Ostarine can be incorporated into various phases of training:

1. Solo compound: Used as a standalone performance enhancer

2. Stacking: Combined with other compounds for enhanced results

3. Post-cycle therapy (PCT): Due to its minimal suppression profile

4. Bridging: Between cycles to maintain gains

---

Healing and Recovery Properties

One of the most distinctive features of Ostarine is its ability to strengthen bones, tendons, and ligaments. This makes it particularly valuable for athletes dealing with nagging injuries such as:

• Forearm and shin splints

• Joint pain and inflammation

• Neck and back pain

• Tendon and ligament strains

At doses under 20mg per day, Ostarine works by increasing tendon strength, ligament strength, and bone density. Unlike painkillers that merely mask symptoms, Ostarine addresses the underlying tissue damage, promoting actual healing rather than temporary relief.

---

Female Use

Ostarine is considered a safer alternative for women compared to anabolic steroids because it does not cause virilization symptoms such as facial hair growth, enlarged clitoris, or other masculine traits. Women often respond favorably to Ostarine, with noticeable reductions in body fat and gains in lean muscle at appropriate dosages.

---

Stacking Options

Depending on individual objectives, Ostarine can be stacked in several ways:

Endurance Stack: Combine with Cardarine for increased endurance before workouts or runs.

Anabolic Steroid Stack: Add to an existing anabolic steroid cycle to increase lean muscle mass and strength without additional side effects.

Post-Cycle Therapy or Bridge: At 25mg per day for 4 weeks or less, Ostarine is minimally suppressive and can be incorporated into PCT or bridging phases to maintain strength and muscle.

SARMs Triple Stack: For body recomposition (building muscle while losing fat), Ostarine stacks effectively with Andarine and Cardarine.

---

Side Effects and Safety Profile

Ostarine is not considered liver toxic and does not typically cause blood pressure or other organ strain at recommended dosages. However, users should be aware of potential side effects:

Common side effects may include headache, sleep problems, fertility issues, and nausea.

Serious side effects reported in some cases include heart attack, stroke, liver damage, hallucinations, psychotic-like behavior, and sexual problems.

Gynecomastia: Some users have reported gynecomastia when running high dosages for extended periods. Having an aromatase inhibitor (AI) on hand is recommended as a precautionary measure.

HPTA Suppression: Ostarine suppresses the HPTA by approximately 10-20% compared to 95% seen with anabolic steroids. At doses of 25mg per day for 4 weeks or less, it is minimally suppressive. However, those running higher dosages for longer periods should implement a proper PCT protocol.

Liver Toxicity: Recent reports have documented cases of liver toxicity in regular users. The production of cyanophenol-sulfate may participate in the mechanism of Ostarine liver toxicity.

---

Dosage and Administration

Half-life: Ostarine has a robust 24-hour half-life, allowing for once-daily dosing.

Recommended Dosage Range: 12.5-50mg per day

• Lower end (12.5-20mg): Suitable for healing, joint recovery, and maintenance

• Mid-range (20-30mg): Balanced approach for muscle preservation and modest gains

• Higher end (30-50mg): For significant recomping and muscle mass gains

Administration Instructions:

• Take once daily at the same time each day

• Tablets should be swallowed whole with water or juice

• Do not crush or chew tablets

---

Doping Status

All SARMs, including Ostarine, have been banned by the World Anti-Doping Agency (WADA) since 2008. Ostarine is classified as a non-Specified Substance under the S1 Anabolic Agent category of the WADA Prohibited List. Athletes subject to anti-doping regulations should be aware that a first violation for a non-Specified Prohibited Substance attracts a four-year ban.

Between 2011 and 2024, 863 adverse analytical findings for SARMs were reported globally, with over half reported between 2020 and 2024.

---

Odin Ostarine 30mg 30 Tablets (MK-2866) represents a premium pharmaceutical-grade SARM for those seeking to enhance performance, preserve muscle mass, and support joint health. Each batch is manufactured to the highest quality standards, ensuring purity and potency.

Order your supply today at: https://anabolicsteroidsonline.shop/

---

Top 10 Frequently Asked Questions

1. What is Ostarine (MK-2866)?

Ostarine, also known as Enobosarm or GTX-024, is a selective androgen receptor modulator (SARM) that selectively binds to androgen receptors in muscle and bone tissue. It was originally developed to treat muscle wasting conditions and osteoporosis.

2. Is Ostarine safe to use?

Ostarine is not approved by the FDA for human use and is considered an investigational drug. Clinical trials and case studies have linked SARMs to severe adverse effects including liver injury, increased heart attack and stroke risk, and hormonal dysregulation. Users should consult with a healthcare provider before use.

3. What is the recommended dosage of Ostarine?

The typical dosage ranges from 12.5-50mg per day, taken once daily due to its 24-hour half-life. Lower doses (12.5-20mg) are used for healing and joint recovery, while higher doses (30-50mg) are for muscle mass gains and body recomposition.

4. Does Ostarine cause testosterone suppression?

Ostarine suppresses the HPTA by approximately 10-20%, significantly less than the 95% suppression seen with anabolic steroids. However, suppression does occur, particularly at higher doses and longer durations.

5. Can women use Ostarine?

Yes, Ostarine can be used by women as it does not cause virilization symptoms such as facial hair growth or enlarged clitoris. Women often respond favorably to Ostarine at appropriate dosages.

6. Is Ostarine legal?

In the United States, Ostarine is an unapproved drug and cannot be legally sold as a dietary supplement. No SARM has been approved by any medicines or food regulator for human use. The FDA does not consider Ostarine to be a legal dietary ingredient.

7. What are the side effects of Ostarine?

Common side effects include headache, sleep problems, fertility issues, and nausea. Serious side effects may include heart attack, stroke, liver damage, hallucinations, and sexual problems. Recent reports have documented cases of liver toxicity in regular users.

8. Is Ostarine banned in sports?

Yes, Ostarine has been banned by WADA since 2008 and is classified as a non-Specified Substance under the S1 Anabolic Agent category. A first violation attracts a four-year ban.

9. Can Ostarine cause gynecomastia?

Some users have reported gynecomastia when running high dosages for extended periods. Having an aromatase inhibitor (AI) on hand is recommended as a precautionary measure.

10. Do I need post-cycle therapy (PCT) after using Ostarine?

At doses of 25mg per day for 4 weeks or less, Ostarine is minimally suppressive and PCT may not be necessary. However, those running higher dosages for longer periods should implement a proper PCT protocol.

---

References and Reputable Sources

• WebMD – Ostarine Overview, Uses, Side Effects: https://www.webmd.com/vitamins-supplements/ostarine

• FDA Warning on SARMs: https://www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults

• UK Anti-Doping – About SARMs: https://www.ukad.org.uk/anabolic-steroids-and-ipeds/about-sarms

• PMC – Ostarine Metabolism and Doping: https://pmc.ncbi.nlm.nih.gov/articles/PMC11277069/

• AMD Alliance – Ostarine Clinical Research: https://www.amdalliance.org/ostarine-mk-2866-for-age-related-muscle-loss/

• Medical News Today – Phase II Clinical Trial Results: https://www.medicalnewstoday.com/releases/153779

• World Anti-Doping Agency Prohibited List: https://www.wada-ama.org/en/prohibited-list